Global Medical REIT Inc (NYSE: GMRE) closed the day trading at $8.38 up 0.60% from the previous closing price of $8.33. In other words, the price has increased by $+0.05 from its previous closing price. On the day, 581522 shares were traded.
Ratios:
For a better understanding of GMRE, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 74.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.41. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 1.07.
On October 06, 2022, BMO Capital Markets Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $13 to $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GMRE now has a Market Capitalization of 546.24M and an Enterprise Value of 1.24B. As of this moment, Global’s Price-to-Earnings (P/E) ratio for their current fiscal year is 37.13, and their Forward P/E ratio for the next fiscal year is 147.87. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.13. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.51 while its Price-to-Book (P/B) ratio in mrq is 1.08. Its current Enterprise Value per Revenue stands at 8.79 whereas that against EBITDA is 11.10.
Stock Price History:
Over the past 52 weeks, GMRE has reached a high of $11.59, while it has fallen to a 52-week low of $8.04. The 50-Day Moving Average of the stock is 9.47, while the 200-Day Moving Average is calculated to be 9.61.
Shares Statistics:
Over the past 3-months, GMRE traded about 369.13K shares per day on average, while over the past 10 days, GMRE traded about 556.88k shares per day. A total of 65.56M shares are outstanding, with a floating share count of 61.79M. Insiders hold about 5.77% of the company’s shares, while institutions hold 57.94% stake in the company. Shares short for GMRE as of Feb 29, 2024 were 1.16M with a Short Ratio of 3.13, compared to 1.16M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.76% and a Short% of Float of 1.87%.
Dividends & Splits
GMRE’s forward annual dividend rate is 0.84, up from 0.84 a year ago. Against a Trailing Annual Dividend Yield of 10.08%, it implies a Forward Annual Dividend Yield of 10.08%. The stock’s 5-year Average Dividend Yield is 7.06. The current Payout Ratio is 372.34% for GMRE, which recently paid a dividend on Apr 09, 2024 with an ex-dividend date of Mar 21, 2024. Stock splits for the company last occurred on Nov 17, 2014 when the company split stock in a 1:400 ratio.
Earnings Estimates
Current recommendations for the stock of the company come from 3 analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0.02 and a low estimate of -$0.01, while EPS last year was $0.01. The consensus estimate for the next quarter is $0, with high estimates of $0.02 and low estimates of -$0.01.
Analysts are recommending an EPS of between $0.07 and -$0.02 for the fiscal current year, implying an average EPS of $0.01. EPS for the following year is $0.03, with 2 analysts recommending between $0.05 and $0.01.
Revenue Estimates
6 analysts predict $33.94M in revenue for the current quarter. It ranges from a high estimate of $35.22M to a low estimate of $32.88M. As of the current estimate, Global Medical REIT Inc’s year-ago sales were $36.23M, an estimated decrease of -6.30% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $33.94M, a decrease of -6.60% less than the figure of -$6.30% in the same quarter last year. There is a high estimate of $35.24M for the next quarter, whereas the lowest estimate is $32.7M.
A total of 7 analysts have provided revenue estimates for GMRE’s current fiscal year. The highest revenue estimate was $142.21M, while the lowest revenue estimate was $131.46M, resulting in an average revenue estimate of $136.14M. In the same quarter a year ago, actual revenue was $141.05M, down -3.50% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $142.09M in the next fiscal year. The high estimate is $149.79M and the low estimate is $134.64M. The average revenue growth estimate for next year is up 4.40% from the average revenue estimate for this year.
